Clinical trial NCT01889030: Cardiovascular Risk Stratification of Ambulatory Patients in Primary Prevention
Official title: Cardiovascular Risk Stratification of Ambulatory Patients in Primary Prevention. RISK Study
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Cardiovascular Primary Prevention
Keywords: Cardiovascular primary prevention
Cardiovascular risk strtification
Lead sponsor: AstraZeneca
Sponsor class: INDUSTRY
First posted: 2013-06-28
Enrollment: 516
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients older than 18 years old, without known vascular disease (primary prevention) under follow-up by the investigator, whose medical records were initiated during the past 3 years and have completed their baseline assessment of CV risk

Brief summary: This is an observational, cross-sectional, national multicenter study, trying to obtain local data about the global cardiovascular risk profile of patients attending ambulatory offices of general practitioners and cardiologists.

The aim of the study is to describe how physicians diagnose and stratify their patients in cardiovascular primary prevention setting and to highlight if patients are stratify through objective tools (risk scores and in this case, wich of them are used) or in subjective ways (clinical evaluation).

Detailed description: This is an observational, cross-sectional, national multicenter study, trying to obtain local data about the global cardiovascular risk profile of patients attending ambulatory offices of general practitioners and cardiologists.

The aim of the study is to describe how physicians diagnose and stratify their patients in cardiovascular primary prevention setting and to highlight if patients are stratify through objective tools (risk scores and in this case, wich of them are used) or in subjective ways (clinical evaluation).

Eligibility criteria: Inclusion Criteria:

* Patients older than 18 years of age, who give their written consent to take part.
* Patients without known vascular disease (primary prevention) under follow-up by the investigator, whose medical records have been initiated during the last 3 years.
* Patients who have completed their baseline CV risk assessment Lipid lowering treatment naive patients at the time of the stratification.

Exclusion Criteria:

* Incomplete or missing medical record data.
* Subjects with prior cardiovascular disease (peripheral vascular disease, coronary or cerebrovascular disease) symptomatic or asymptomatic.
* Subjects with terminal status disease or short life expectancy.
* Hypothyroidism without proper control.
* Pregnancy.
* Medical records compiled within a period longer than 3 years to the date of inclusion.

Primary outcomes:
measure: Desciption of the assessment methods used to define the cardiovascular risk profile of patients attending outpatient medical consultation.
timeFrame: Day 1
Secondary outcomes:
measure: Comparison of the subjective individual risk assessment vs. the objective assessment obtained by the WHO risk score.
timeFrame: Day 1
measure: Comparison of the objective individual risk assessment achieved by the use of any risk score chosen by the treating physician in his / her usual practice vs. the objective assessment obtained by WHO risk score.
timeFrame: Day 1
measure: Description of the treatment used, according to risk group and by the specialty of the treating physician.
timeFrame: Day 1
measure: Description of the extent of use of other diagnostic methods to define the individual cardiovascular risk (imaging scans, biomarkers).
timeFrame: Day 1
Other outcomes:
Locations:
city: Buenos Aires
country: Argentina
facility: Research Site
Study officials:
References: